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The outcome of 30 consecutive patients with active aortic pros· 
thetic valve endocarditis and root abscesses treated by the tech· 
nique of homograft aortic root replacement with reimplantation of 
the coronary arteries is detailed. The principles of this technique 
are the removal of all abscesses and infected areas likely to drain 
into the infected mediastinum, excision of infected tissues down to 
healthy noninfected tissue and replacement with an antibiotic· 
impregnated homograft aortic root. 
All patients had evidence of progressive cardiac failure and 
ongoing sepsis. Mean patient age (± SD) at the time of operation 
was 42 ± 18 years. The mean number of previous aortic valve 
replacements per patient was 1.6 ± 0.7; 14 patients (47%) had 
Prosthetic valve endocarditis is a devastating although rela· 
tively uncommon complication of cardiac valve replace· 
ment. It complicates approximately 2% to 4% of valve 
replacement operations (1-5) and is associated with a mor· 
tality rate >50% (1-4). Increasing surgical expertise and the 
high mortality rate with medical management have led to a 
widespread recommendation for early valve replacement in 
many patients with prosthetic valve endocarditis (l,2,4,6). 
At times, the infective process is so destructive that simple 
debridement and valve replacement are not sufficient (2). 
This is the case in patients with destructive aortic prosthetic 
valve endocarditis and aortic root abscesses. A number of 
techniques to treat such patients have been described (7-13). 
In this report, we describe our experience with regard to one 
of these techniques, homograft aortic root replacement, in 30 
consecutive patients with complicated aortic prosthetic 
valve endocarditis. 
Methods 
Study patients (Table 1). Between November 1972 and 
August 1989, 30 patients suffering from active complicated 
prosthetic aortic valve endocarditis and requiring emergency 
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undergone 2:2 previous replacements. At operation, aortic root 
abscesses were found in all patients; abscess extension to adjacent 
structures and partial valve dehiscence had occurred in 23. 
In.hospital death occurred in 9 (30%) of the 30 patients. 
The 21 hospital survivors have been followed up for a mean of 
66 ± 42 months (range 9 to 144). Overall, 17 (81 %) of the 21 
hospital survivors have remained free of major adverse events 
(recurrence of endocarditis, need for reoperation or death). The 
results of our study suggest that homograft aortic root replace· 
ment should be considered favorably in the treatment of patients 
with aortic prosthetic valve endocarditis and root abscesses. 
(J Am Coll CardioI1991;17:1177-82) 
surgery were selected for homograft aortic root replacement. 
For the purposes of this study, clinical and operative details 
were obtained retrospectively through review of the hospital 
charts. 
The mean patient age (± SD) was 42 ± 18 years (range 7 
to 74). Twenty patients were male, 10 female. All patients 
had evidence of hemodynamic decompensation with ongoing 
sepsis. Fever was present in 30 (100%) and newly developed 
aortic regurgitation in 21 (70%). Peripheral manifestations of 
endocarditis (defined as the presence of one or more of the 
following: petechiae, splinter hemorrhages, Roth spots, Jane· 
way lesions, Osler nodes, unexplained embolus or unex· 
plained anemia) were present in 26 (87%), splenomegaly in 
16 (53%) and new high grade cardiac conduction abnormal-
ities in 3 (10%). The mean number of previous aortic valve 
replacements per patient was 1.6; 14 patients (47%) had had 
2':2 previous aortic valve replacements. 
The onset of prosthetic valve endocarditis was taken as 
the earliest of 1) the date of the first physician visit for an 
illness eventually proved to be prosthetic valve endocarditis; 
2) the date of the first positive blood culture for an organism 
eventually shown to be the causative pathogen of prosthetic 
valve endocarditis; or 3) the date of hospital admission. 
Prosthetic valve endocarditis was defined as early when it 
appeared within 60 days of valve insertion and late when it 
occurred after 60 days. 
Operative technique. A median sternotomy was used and 
the right atrial appendage and ascending aorta were cannu· 
lated for cardiopulmonary bypass. On bypass, the patient's 
body temperature was cooled to 28°C, the aorta was cross 
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Table 1. Clinical Characteristics and In-hospital Outcome of 30 Patients Undergoing Homograft Aortic Root Replacement 
No. 
New Prev 
Pt Age (yr)1 Cond Ao V Infected Aortic Onset 
No. Gender Fever AR PM SM Abnl Repl Prosthesis ElL Organism Grown Outcome 
391M + + Hall-Medtronic E Strep viridans Survival 
2 73/M + + + Carpentier-Edwards L Strep viridans Survival 
xenograft 
3 54/M + + + Starr-Edwards L Strep viridans Survival 
4 261M + + + I Autograft L Staph epidermidis Survival 
5 351M + + + + 3 Bjork-Shiley E Survival 
6 70/M + + St. Jude L Strep lecalis Survival 
7 48/M + + Carpenter-Edwards L Strep viridans Survival 
xenograft 
8 45/F + + + 2 Starr-Edwards L Strep mutans Survival 
9 7/F + + I Starr-Edwards E Staph epidermidis Survival 
\0 40/M + + 2 Starr-Edwards L Staph epidermidis Survival 
11 22/F + + Homograft L Strep sanguis Survival 
12 48/F + + Bjork-Shiley L Survival 
13 301M + + + Starr-Edwards L Survival 
14 38/F + + + + 2 Starr-Edwards L Staph epidermidis Survival 
15 361M + + + + I Starr-Edwards L Staph aureus Survival 
16 40/M + + + + 2 Starr-Edwards L Staph aureus Survival 
17 4l1F + + + + Homograft L Staph epidermidis Survival 
18 15/F + + + + Carpentier-Edwards L H parainfluenza Survival 
xenograft 
19 59/M + + + + 2 Carpentier-Edwards L Strep mitior Survival 
xenograft 
20 5 11M + + + + 2 Starr-Edwards L Strep viridans Survival 
21 63/F + + + + 2 Carpentier-Edwards L Strep mutans Survival 
xenograft 
22 351M + + + Hall-Kaster E Staph epidermidis Death 
23 55/M + + + 2 Starr-Edwards E Staph epidermidis Death 
24 461M + + 2 Pericardial E Staph epidermidis Death 
xenograft 
25 14/F + + + CHB 3 Bjork-Shiley L Strep mitis Death 
26 281M + + + CHB I Bjork-Shiley E Staph aureus Death 
27 59/F + + + CHB 2 Medtronics L Strep viridans Death 
28 571M + + + Carpentier-Edwards E Staph epidermidis Death 
xenograft 
29 151M + + + + Carpentier-Edwards E Staph epidermidisl Death 
xenograft Staph aureus 
30 74/M + + + + 2 Starr-Edwards L Staph epidermidisl Death 
Staph aureus 
AR = aortic regurgitation; CHB = complete heart block; ElL = early/late onset of prosthetic valve endocarditis; F = feminine; H = Haemophilus; M = 
masculine; New Cond Abnl = new high grade conduction abnormalities; No. Prev Ao V Repl = number of previous aortic valve replacements; PM = peripheral 
manifestations of endocarditis; Pt. = patient; SM = splenomegaly; Staph = Staphylococcus; Strep = Streptococcus; - = absent; + = present. 
clamped and an oblique aortotomy was made extending of the right coronary cusp into the septum anteriorly and 
down into the sinus of the noncoronary cusp. The coronary across the subvalvular curtain of the mitral valve posteri-
arteries were cannulated during dissection to prevent embo- orly. In the angle between the right and noncoronary cusps, 
lization by debris. After removal of the infected prosthesis the incision was extended to the upper margin of the 
and excision of the necrotic tissue down to healthy tissue, a membraneous septum to avoid damage to the conducting 
homograft aortic root was inserted and the coronary arteries systems. The coronary orifices were preserved with a 3 mm 
were reimplanted into the homograft. The infected bed of the cuff of surrounding aortic wall. Once both coronary arteries 
previous valve site was treated with weak iodine solution. had been identified, a curved probe was passed into them to 
The upper limit of the aortic incision was ~ 1 cm above identify their direction during subsequent mobilization_ All 
any evidence of infected tissue, and the lower extent of the abscess cavities were widely opened and allowed to drain 
incision was across the outflow tract of the left ventricle into the surrounding mediastinum_ 
down to healthy tissue and generally at the point of insertion Multiple, interrupted 4-0 Prolene sutures were then at-
JACC Vol. 17, No.5 
April 1991:1177-82 
tached to the lower margin of the horizontally trimmed 
homograft and the corresponding areas of the healthy aortic 
root tissues. At least 28 sutures were required, dividing the 
circumference into four sections with 7 to 8 sutures each. It 
was convenient to tie down the sutures over a thin strip of 
autogenous pericardium to aid hemostasis and avoid cutting 
through the muscles of the homograft. The left coronary 
artery and its disc of aortic wall were then attached to the 
corresponding excised orifice in the left coronary sinus of the 
homograft with a continuous 6-0 Prolene suture. 
The upper margin of the homograft was trimmed and 
sewn to the transected aorta with continuous 4-0 Prolene 
sutures, with a temporary clamp on the right coronary 
ostium of the homograft. The aortic clamp was then released 
and the new aortic root was observed under pressure, 
enabling hemostasis to be checked and indicating the best 
site of attachment of the right coronary artery. This was a 
necessary precaution because the position of this artery is 
variable and might not correspond with the appropriate 
orifice in the homograft. The aortic clamp was then reapplied 
and the right coronary artery was anastomosed. 
Patient follow-up. This was achieved by annual clinical 
examination and by telephone or postal questionnaire. Each 
patient routinely had a 12 lead electrocardiogram (EeG) at 
rest, chest X-ray film and Doppler echocardiographic study 
on an annual basis. 
Statistical analysis. Wilcoxon's rank test, Student's t test 
and Fisher's exact test were performed to determine possi-
ble differences in clinical characteristics between the pa-
tients who died in hospital and those who survived. A 
p value <0.05 was considered statistically significant. 
Results 
Infected prosthesis and microbiology (Table 1). Preopera-
tive isolation of the infecting organism was obtained in 23 of 
the 30 patients. In a further four patients, the infecting 
organisms were identified postoperatively either from the 
excised prosthesis or from vegetations. Staphylococcus was 
identified as the causative organism in 14 patients; in 9 of 
these 14 patients S. epidermidis alone was isolated and in 3, 
S. aureus alone. In the remaining two patients with staphy-
lococcal infection, there was a mixed growth of S. aureus 
and S. epidermidis. Streptococcus was the infecting organ-
ism in 12 patients and Haemophilus parainfluenza in l. 
Prosthetic valve endocarditis was judged as late in onset in 
21 patients and early in 9 (Table I). Infection occurred on a 
mechanical aortic valve prosthesis in 19 patients and on a 
bioprosthesis in II. 
Operative findings. At operation, aortic annular ab-
scesses were found in all patients. In 23 patients, the ring 
abscesses burrowed into adjacent structures (extending into 
the periaortic space in 12 patients, the left or right atrium in 
lO and the interventricular septum in 3 and burrowing 
through the anterior mitral valve cusp in 4). Twenty-three of 
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Table 2. Comparison of Clinical Characteristics of 21 Patients 
Surviving and 9 Not Surviving Homograft Aortic Root Replacement 
In-Hospital Hospital 
Death Survivors p Value 
Age (yr) 43 ± 21* 42 ± 17* NS 
Male (no.) 7 13 NS 
No. of previous aortic 1.67 ± 0.7* 1.52 ± 0.68* NS 
valve replacements 
Early onset 6 <0.02 
New onset aortic 7 14 NS 
regurgitation 
New high grade cardiac 3 0 <0.05 
conduction abnormalities 
Mechanical prosthesis 6 13 NS 
Staphylococcal etiology 7/9 7/18t 0.13 
*Mean ± SD; tinfecting organism identified in only 18 of the 21 hospital 
survivors. 
the 30 aortic valve prostheses were noted to be partially 
detached. 
In-hospital death. This occurred in 9 (30%) of the 30 
patients. Five of these patients had been transferred to our 
care from other cardiac surgery centers after unsuccessful 
surgical-medical (four patients) or medical (one patient) 
treatment of endocarditis. Of these five patients, three were 
in extremis with advanced cardiac failure and established 
renal failure and two had complete heart block. Three 
patients died in the operating room. Of the remaining six 
in-hospital deaths, four occurred between 3 and 14 days 
postoperatively as a result-of progressive heart failure (com-
bined with progressive renal failure in two). The remaining 
two patients died 4 and 8 weeks after surgery; one died of 
uncontrolled septicemia, the other of massive bleeding from 
a false aneurysm originating from a proximal suture line 
defect. 
Predictors of unfavorable outcome (Table 2). The clinical 
characteristics of the group of patients who died in the 
hospital and those who survived the hospital stay are com-
pared in Table 2. There were two statistically significant 
predictors of in-hospital death: I) early onset of prosthetic 
valve endocarditis (p < 0.02), and 2) recent onset high grade 
cardiac conduction defects (p < 0.05). A staphylococcal 
etiology was identified in 7 (78%) of the 9 patients who died 
in the hospital, but in only 7 (39%) of the 18 hospital 
survivors in whom an organism was isolated (p = NS). 
Out-of-hospital course. The 21 hospital survivors have 
been followed up for a mean of 66 ± 42 months (range 9 to 
144). During this period, the following events occurred: 
Recurrence of endocarditis. This occurred in 2 (9.5%) of 
the 21 patients. One patient (Patient 18) developed en-
docarditis 5 years after aortic root replacement. The organ-
ism isolated (a streptococcus) was different from the organ-
ism responsible for this patient's original prosthetic valve 
endocarditis. She was successfully treated with medical 
therapy alone. The second patient (Patient 5), who devel-
oped recurrence of endocarditis 8 months after aortic root 
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replacement, underwent successful reoperation (repeat ho-
mograft aortic root replacement). In this patient, no organ-
ism had been identified when the first homograft aortic root 
was inserted, but at the time of repeat operation, laboratory 
investigations diagnosed Q fever (Coxiella burnetti) en-
docarditis. 
Need for repeat operation. This occurred in four pa-
tients. One patient (Patient 5) underwent repeat aortic root 
replacement for recurrence of endocarditis. Two patients 
(Patients 18 and 14) who had primary tissue failure were 
reoperated on 7.5 and 10 years, respectively, after initial 
aortic root replacement. The first of these two patients was 
the patient, previously mentioned, whose recurrence of 
endocarditis was successfully treated medically. In both 
patients, the predominant lesions were calcification of the 
homograft wall and extension of the calcification to the 
cusps. In neither patient was aneurysmal dilation of the 
homograft or stenosis of the coronary ostia encountered. 
The fourth patient (Patient 16), who required reoperation as 
a result of progressive cardiac failure, underwent cardiac 
transplantation 9 years after aortic root replacement. 
Death. This occurred perioperatively in the two patients 
undergoing reoperation for primary tissue failure. There 
were no other deaths, either cardiac or noncardiac. 
Patients who have remained event free. Among the 17 
patients who have remained event free, follow-up study to at 
least May 1990 has been achieved in all. Two of these 17 
patients, both aged >70 years and with previous sympto-
matic valvular heart disease, have moderately severe (func-
tional class III) symptoms of heart failure. At a mean 
follow-up interval of 61 ± 43 months, the other 15 are either 
asymptomatic or only mildly symptomatic. One of these 15 
patients has developed aortic regurgitation that is asympto-
matic and graded as mild to moderate by Doppler echocar-
diography. 
Discussion 
Our study examined the daunting therapeutic challenge 
posed by patients with active aortic prosthetic valve en-
docarditis. In such patients, aortic root abscesses, often with 
associated valve dehiscence and abscess extension to adja-
cent structures, are virtually the rule (14). Indeed, all of our 
30 patients had ring abscesses that extended to adjacent 
structures in 23. Given the uniform clinical picture of pro-
gressive cardiac failure and ongoing sepsis in these patients, 
urgent surgical intervention was clearly indicated in all. 
However, the operative findings in these patients made it 
equally obvious that simple replacement of the infected 
prosthesis would not eradicate the infection and more radical 
surgery was required. 
Surgical approaches used in the treatment of aortic pros-
thetic valve endocarditis and annular abscess formation. Sev-
eral innovative surgical techniques have been applied to 
small numbers of patients with aortic prosthetic valve en-
docarditis and left ventricular-aortic discontinuity. Symbas 
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et al. (7) reported successful patch closure of the abscess and 
in situ valve replacement in one patient. Reitz et al. (8) 
described successful treatment of three of four patients by 
translocation of the aortic valve, closure of the native 
coronary ostia and placement of saphenous vein bypass 
grafts to the coronary arteries. Frantz et al. (9) used com-
posite prosthetic valve-woven Dacron tube graft reconstruc-
tion of the aortic root to treat two patients (with success in 
one). This latter technique was also successfully applied by 
Van Hooser et al. (10) in three patients with prosthetic valve 
endocarditis and aortic root abscesses. Kirklin et al. (11) 
reported the successful treatment of a patient with infection 
of an aortic mechanical valve and an annular abscess using 
an aortic valve homograft placed below the level of the 
coronary ostia. 
Despite the favorable results obtained with these tech-
niques (7-11), it is often insufficient just to replace the 
infected prosthesis and attempt to paper over the pus and 
infected material with pericardial patches or Dacron mate-
rial. To do so is to ignore the hallowed surgical rubric: "do 
not let the sun set on undrained pus." Simply covering over 
infected material and cavities creates a slowly developing 
infected focus that will continue to fester, grow in size and 
eventually burst into the area of least resistance (which is 
generally back into the bloodstream), possibly months later 
(15). The technique performed in our study patients, ho-
mograft aortic root replacement, avoids these problems. 
First performed by Ross (15) in 1972, this technique excludes 
the root abscesses and the weakened infected aortic anulus 
from high systemic pressures and permits suturing to a bed 
of the aortic root in continuity with healthy myocardium 
(12,13,15). 
Outcome in complicated aortic prosthetic valve endocardi-
tis. In our study, the technique of homograft aortic root 
replacement was used in 30 critically ill patients with aortic 
prosthetic valve endocarditis and root abscesses. In-hospital 
death occurred in 9 (30%). Of the 21 hospital survivors, at a 
mean follow-up interval of 66 ± 42 months, 17 (21%) have 
remained free of major adverse events. 
Taking into account the clinical presentation of our 
patients, an in-hospital mortality rate of 30% is not surpris-
ing. The mean number of previous aortic valve operations 
per patient was 1.6 ± 0.7, with 14 (47%) having had ~2 aortic 
valve operations. These features alone would have put them 
at a considerably increased surgical risk (16). In addition, all 
had hemodynamic decompensation and active endocarditis, 
many with multisystem failure. Of the nine patients who died 
peri operatively , three were in extremis on arrival in the 
operating room with cardiogenic and septic shock. In our 
study, early onset prosthetic valve endocarditis and new 
onset complete heart block emerged as predictors of in-
hospital death. The higher mortality rate in patients with 
early as opposed to late prosthetic valve endocarditis ob-
served in our series has also been found in all major studies 
(2) examining prognostic features in prosthetic valve en-
docarditis. This observation most likely reflects the more 
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virulent organisms associated with early as opposed to late 
prosthetic valve endocarditis (in our series, compared with 
the patients with late onset endocarditis, staphylococcus 
was isolated in proportionately twice as many patients with 
early onset endocarditis) and debilitation of patients after 
operation (2). New onset complete heart block suggests 
extensive abscess extension and infiltration and thus the 
poor prognosis in patients developing this rhythm distur-
bance is not surprising. 
Previous studies. Reported large series regarding the fate 
of patients with prosthetic valve endocarditis treated surgi-
cally contain a considerable case mix. In these studies, 
patients with aortic, mitral, complicated and uncomplicated 
prosthetic valve endocarditis are not clearly differentiated. 
However, Masur and Johnson (4) reported the alarming 
observation that of 14 patients with aortic prosthetic valve 
endocarditis treated with a combined medical-surgical ap-
proach, only 1 survived. Ivert et al. (3) reported on 33 
patients with prosthetic valve endocarditis (location not 
detailed) treated surgically at their center. The overall in-
hospital mortality rate was 36% and 11 (44%) of 25 patients 
surviving the first repeat operation needed two or more 
repeat operations. Two of the 11 patients who underwent a 
second repeat operation had certain recurrent or residual 
prosthetic valve endocarditis and 1 had possible prosthetic 
valve endocarditis. Of the four patients in the series of Ivert 
et al. (3) undergoing a third repeat operation, one had certain 
prosthetic valve endocarditis and one had possible pros-
thetic valve endocarditis. Of 21 patients surviving one or 
more repeat operations and discharged from the hospital, 3 
(14%) died of another recurrence of prosthetic valve en-
docarditis and another 2 died of heart failure. 
Although the study of Ivert et al. (3) was not limited to 
patients with aortic prosthetic valve endocarditis, their re-
sults highlight the notorious tendency for prosthetic valve 
endocarditis to recur and the considerable in-hospital and 
late mortality rates associated with this condition. Accord-
ingly, the relatively low rate of adverse events at intermedi-
ate- to long-term follow-up study observed in our series is 
encouraging. Given the very septic state of our study pa-
tients at the time of presentation, the rate of recurrence of 
endocarditis after homograft aortic root replacement (2 of 21 
patients) is low and a gratifying feature of this radical 
operation. In contemplating the relatively low endocarditis 
recurrence rate in our series, a relevant consideration is that 
homograft valves, as opposed to other bioprosthetic or 
mechanical valves, are reported (17) to be more resistant to 
infection, at least during the first few years after implanta-
tion. A further important consideration is that none of our 
patients were known intravenous drug abusers. 
Limitations of the present study. A potential limitation of 
our study is that comprehensive data regarding the long-term 
(~1O years) consequences of use of homograft aortic root 
replacement in patients with complicated aortic prosthetic 
valve endocarditis cannot be provided because only four of 
the hospital survivors in our series underwent the procedure 
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during or before 1980. However, the results of several 
reported studies (18,19) involving large series of patients 
undergoing this operation for conditions in addition to pros-
thetic valve endocarditis (such as for relief of various types 
of left ventricular outflow tract obstruction) suggest that the 
homograft aortic root is a very durable structure. This 
observation is not particularly surprising if one realizes that 
the technique leaves the aortic valve undisturbed within its 
native tubular structure and does not require any geometric 
wizardry to match it to a new home (20). This results in the 
invariable insertion of a competent mechanism that is undis-
turbed by surrounding tissue and that causes no turbulence. 
Indeed, the probability of freedom from valve failure in the 
homograft root has been estimated at about 92% at 10 years 
(21). Of course, in many centers there is limited availability 
of homograft tissue. 
Conclusions. Homograft aortic root replacement appears 
particularly useful when it is difficult to place a conventional 
homograft or autograft because there has been ring destruc-
tion by infection. On the basis of the encouraging results 
observed in our patients, we suggest that this technique 
should be considered favorably in selected patients with 
active aortic prosthetic valve endocarditis and annular ab-
scess formation. 
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